IPP Bureau
MicroGEM granted EUA for Covid-19 PCR Saliva test
By IPP Bureau - April 20, 2022
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
By IPP Bureau - April 19, 2022
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Asahi Kasei Medical to acquire US based CDMO Bionova Scientific
By IPP Bureau - April 19, 2022
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India
By IPP Bureau - April 19, 2022
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
By IPP Bureau - April 19, 2022
The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19
Bollywood actor Sonu Sood joins hands with Aster Volunteers to raise awareness on liver disease
By IPP Bureau - April 19, 2022
Through the association, Aster Volunteers would support 50 children from underprivileged families undergo liver transplants at Aster CMI and Aster RV Hospitals in Bangalore, and Aster Medcity and Aster MIMS Hospital Calicut in Kerala, India
Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
By IPP Bureau - April 19, 2022
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
By IPP Bureau - April 19, 2022
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
UFlex-Asepto to set up India’s first U-shaped paper straw line for aseptic liquid cartons
By IPP Bureau - April 19, 2022
New product line to address the challenge of restrictions on use of plastic straws
Intas Pharmaceuticals and Comera Life Sciences announce research collaboration
By IPP Bureau - April 19, 2022
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
AI driven Israeli company Embryonics ties-up with Jaslok Hospital
By IPP Bureau - April 19, 2022
The data driven fertility company helps increase the success rate of fertility treatments
Akron Bio completes plasmid DNA manufacturing facility
By IPP Bureau - April 19, 2022
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
PM Narendra Modi lays down five goals for new WHO Global Centre
By IPP Bureau - April 19, 2022
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
E-learning in diabetes management for nurses launched
By IPP Bureau - April 19, 2022
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system
By IPP Bureau - April 18, 2022
The HD-550 endoscopy system has been available outside of the USA since 2019
